Laurus Labs shares tumble nearly 9% after promoters sell stake worth Rs 500 crore; multibagger stock up 122% in one yearLaurus Labs shares fell nearly 9% after promoters, including founder and CEO Satyanarayana Chava, sold over 20 lakh shares worth Rs 487 cro...
16 Nov, 2026, 02.26 PM IST
Oyster Renewable to complete Rs 350-crore wind-solar project in Andhra Pradesh by DecemberOyster Renewable Energy is nearing completion of a 60.9 MW wind-solar hybrid project in Kadapa district. The project will be operational by...
12 Nov, 2026, 04.24 PM IST
Jensen Huang pulls out of Anthropic and ElevenLabs events after affair admission as Nvidia investigates Alice Huang's alleged China spy linksNvidia CEO Jensen Huang is no longer expected at Anthropic’s CEO Forum and has disappeared from the ElevenLabs Summit lineup. The changes c...
11 Nov, 2026, 10.23 PM IST
Ahead of Market: 10 things that will decide stock market action on WednesdayIndian stock markets recovered from early losses on Monday, with Sensex gaining 107 points and Nifty rising 58 points. Improving foreign in...
10 Nov, 2026, 09.31 PM IST
BDR Pharma to acquire Acme’s oral solid formulations businessBDR Pharma will acquire a controlling stake in Acme Formulation’s oral solid formulations business from existing shareholders, led by priva...
10 Nov, 2026, 04.21 PM IST
Up to 12,000% growth! 181 companies more than doubled profits in Q2 earnings boom for India IncIndia Inc witnessed a strong earnings recovery in Q2 FY27, with 181 companies more than doubling their net profits year-on-year, according ...
10 Nov, 2026, 12.37 PM IST
Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoYGland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. Th...
09 Nov, 2026, 11.21 AM IST
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its t...
09 Nov, 2026, 10.39 AM IST
Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?Divi’s Laboratories shares surged over 8% during Muhurat Trading, hitting a 52-week high after Q2 FY27 net profit jumped 64% to ₹1,127 cror...
09 Nov, 2026, 09.47 AM IST
More than family business: Drugmakers make costly, long-term strategic shifts as next generation steps into bigger rolesIndia's family-run pharmaceutical companies are entering a new phase as the next generation takes on larger leadership roles and steers bus...
07 Nov, 2026, 11.44 PM IST
Diwali 2026 wealth creators: 8 BSE 500 stocks shrug off market weakness, deliver up to 191% returns; do you own any?Eight BSE 500 stocks more than doubled investors’ wealth since Diwali 2025, led by Aditya Infotech, HFCL and Welspun Corp. As Samvat 2083 b...
07 Nov, 2026, 11.53 AM IST
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
05 Nov, 2026, 11.49 AM IST
Dividend alert! Last day to buy Power Grid, NTPC, Info Edge among 26 stocks for dividend rewardsUnder Sebi’s T+1 settlement cycle, investors need to purchase a company’s shares at least one trading day before the record date to ensure ...
05 Nov, 2026, 07.39 AM IST
Diwali 2026: 77 stocks knock down D-St bears to deliver multibagger returns of up to 4,700% in a yearWith Diwali 2026 on the horizon, 77 stocks have thrived despite market fluctuations, marking exceptional returns. Mrugesh Trading showcases...
02 Nov, 2026, 09.53 AM IST
Ahead of Market: 10 things that will decide stock market action on MondaySensex and Nifty ended the week up about 0.5%, supported by resilient large-cap, IT and healthcare stocks. However, midcap and smallcap ind...
01 Nov, 2026, 05.16 PM IST
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...
30 Oct, 2026, 10.31 AM IST
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upsideNuvama Institutional Equities has initiated coverage on Laurus Labs with a ‘Buy’ rating and a target price of Rs 2,520, implying a 24% upsi...
16 Oct, 2026, 03.22 PM IST